| Dr Edwin Manley Briggs, MD | |
|
1316 Harrison Blvd, Boise, ID 83702-3444 | |
| (208) 345-5523 | |
| (208) 389-4606 |
| Full Name | Dr Edwin Manley Briggs |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 1316 Harrison Blvd, Boise, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316028889 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | M2713 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edwin Manley Briggs, MD 1316 Harrison Blvd, Boise, ID 83702-3444 Ph: (208) 345-5523 | Dr Edwin Manley Briggs, MD 1316 Harrison Blvd, Boise, ID 83702-3444 Ph: (208) 345-5523 |
News Archive
Research from Karolinska Institutet in Sweden shows that the human olfactory bulb - a structure in the brain that processes sensory input from the nose - differs from that of other mammals in that no new neurons are formed in this area after birth. The discovery, which is published in the scientific journal Neuron, is based on the age-determination of the cells using the carbon-14 method, and might explain why the human sense of smell is normally much worse than that of other animals.
Despite international praise for Ghana's successful economic growth and its "reputation as a beacon of democracy in Africa," "4,000 women die every year and over 200,000 are disabled due to pregnancy-related complications," Kwesi Owusu, executive producer of the Maternal Health Channel television series, writes in a CNN opinion piece.
ViroPharma Incorporated today announced that it has completed enrollment in its Phase 2 study evaluating subcutaneous delivery of Cinryze™ (C1esterase inhibitor [human]). This multi-center, open-label, multi-dose Phase 2 study is designed to evaluate the safety, pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of Cinryze in adolescent and adult subjects with hereditary angioedema (HAE).
As President Obama and Congress weigh changes in the nation's health care system they must avoid creating a system where physicians are financially motivated to pressure patients into mandated treatments that conflict with their values and needs, two Beth Israel Deaconess Medical Center physicians warn.
Tibotec Pharmaceuticals has announced that the New Drug Application (NDA) for TMC114, an investigational HIV protease inhibitor, has been accepted for priority review by the United States Food and Drug Administration (FDA).
› Verified 3 days ago
Sean Patrick Stroup, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 510 N 2nd St Ste 103, Boise, ID 83702 Phone: 208-381-4700 | |
Dr. Kara C Taggart, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 510 N 2nd St, Suite 103, Boise, ID 83702 Phone: 208-381-4700 Fax: 208-381-4977 | |
Michele B Ebbers, MD Urology Medicare: Medicare Enrolled Practice Location: 305 E Jefferson St, Boise, ID 83712 Phone: 208-381-6196 Fax: 208-381-6199 | |
Dr. Donald E Walker, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 701 E Parkcenter Blvd, Boise, ID 83706 Phone: 208-344-5757 Fax: 208-381-6526 | |
Robert E. Jackson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 520 S Eagle Rd, Suite 3112, Boise, ID 83712 Phone: 208-381-2222 | |
David B Crane, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 305 E Jefferson St, Ste 102, Boise, ID 83712 Phone: 208-343-2820 |